Watchlist Manager

Watchlist

Price: 10 540 KRW 1.84% Market Closed

Market Cap: ₩581.6B

	Shinpoong Pharmaceutical Co Ltd KRX:019170	KR
	GPM Metals Inc XTSX:GPM	CA

Balance Sheet

Currency: KRW

	Dec-2001	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	1 391	865	1 449	2 438	2 574	5 110	2 854	541	2 233	2 332	3 411	5 185	9 894	5 972	12 668	16 094	19 422	37 169	23 374	55 802	27 637	41 691	43 800	41 986
Cash	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	119	1 047	34	41	14	11	1
Cash Equivalents	1 391	865	1 449	2 438	2 574	5 110	2 854	541	2 233	2 332	3 411	5 185	9 894	5 972	12 668	16 094	19 422	37 050	22 327	55 768	27 596	41 677	43 789	41 985
Short-Term Investments	0	10	143	1 120	260	990	1 470	0	230	5 774	3 118	2 661	3 647	4 199	3 622	24 902	22 082	28 099	42 626	134 667	64 883	14 104	16 661	14 373
Total Receivables	72 393	76 662	85 672	92 885	100 986	108 274	108 223	115 497	118 302	160 129	153 541	137 962	142 827	156 688	156 369	151 926	129 447	115 793	101 833	91 014	90 368	90 718	82 103	72 591
Accounts Receivables	72 351	75 636	83 945	90 609	97 840	105 011	105 176	112 586	115 731	160 129	153 541	136 919	142 827	156 688	154 121	148 387	128 999	113 352	99 656	88 712	81 940	82 377	73 869	70 363
Other Receivables	42	1 026	1 727	2 276	3 146	3 263	3 047	2 911	2 571	0	0	1 043	0	0	2 248	3 539	448	2 441	2 177	2 302	8 428	8 342	8 234	2 229
Inventory	13 703	15 526	21 199	20 121	26 659	26 080	28 786	31 726	32 747	40 034	40 728	45 276	43 467	43 946	45 429	42 207	46 929	44 938	49 026	49 088	47 707	46 895	53 923	55 382
Other Current Assets	2 750	902	765	857	1 704	1 230	1 083	497	321	922	969	437	474	516	768	649	949	2 784	2 334	2 240	2 403	3 134	2 448	4 989
Total Current Assets	90 237	93 966	109 227	117 421	132 183	141 684	142 417	148 261	153 833	209 190	201 767	191 520	200 309	211 321	218 857	235 778	218 828	228 782	219 192	332 812	232 997	196 542	198 935	189 321
PP&E Net	15 738	30 725	45 483	46 286	46 880	46 900	62 679	101 184	121 773	141 267	148 971	161 575	161 697	159 941	152 192	144 269	138 192	130 505	130 942	124 177	116 884	113 760	118 638	115 398
PP&E Gross	15 738	30 725	45 483	46 286	46 880	46 900	62 679	101 184	121 773	141 267	148 971	161 575	161 697	159 941	152 192	144 269	138 192	130 505	130 942	124 177	116 884	113 760	118 638	115 398
Accumulated Depreciation	17 391	21 254	26 565	32 548	37 798	42 390	41 046	47 624	55 655	50 138	57 543	64 901	73 630	82 765	92 409	101 712	109 699	119 473	120 344	118 706	129 428	136 261	130 898	139 397
Intangible Assets	15	66	953	2 153	1 988	1 661	817	1 081	1 835	3 376	10 184	11 231	15 951	14 589	12 174	11 275	8 784	7 120	8 914	8 062	8 971	6 931	5 769	5 006
Goodwill	0	0	30	20	10	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Note Receivable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1 950	0	0	0	0	0	0	1	12
Long-Term Investments	8 014	8 568	7 257	6 830	6 793	8 125	8 421	12 189	10 917	13 067	14 815	13 702	15 140	19 159	23 210	17 929	17 491	10 097	14 445	14 876	28 571	29 336	21 107	24 896
Other Long-Term Assets	2 018	3 085	3 302	2 105	2 240	2 698	2 826	5 865	7 789	3 162	2 763	1 652	5 258	4 285	4 298	5 287	7 334	8 626	6 621	7 223	10 927	14 967	5 634	7 459
Other Assets	0	0	30	20	10	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Assets	116 022 N/A	136 409 +18%	166 193 +22%	174 775 +5%	190 075 +9%	201 068 +6%	217 161 +8%	268 580 +24%	296 147 +10%	370 062 +25%	378 500 +2%	379 680 +0%	398 355 +5%	409 295 +3%	410 730 +0%	416 488 +1%	390 630 -6%	385 129 -1%	380 114 -1%	487 150 +28%	398 350 -18%	361 536 -9%	350 084 -3%	342 093 -2%
Liabilities
Accounts Payable	1 952	3 107	5 423	6 056	8 058	5 580	6 550	5 621	7 690	28 474	22 583	25 056	21 600	19 467	17 195	15 905	25 175	21 164	18 373	8 789	12 060	11 428	8 941	9 998
Accrued Liabilities	979	1 541	2 220	2 219	3 244	3 698	3 511	4 489	3 391	0	3 817	2 937	3 650	3 357	3 859	22 342	4 683	4 255	4 772	4 953	7 057	7 300	13 856	9 021
Short-Term Debt	31 127	28 929	41 206	41 067	45 311	45 438	51 920	58 578	77 582	17 672	10 484	107 782	107 865	116 661	143 591	109 041	102 515	105 440	98 507	150	248	0	44 000	47 305
Current Portion of Long-Term Debt	2 890	2 567	2 495	1 942	1 948	6 783	922	1 464	1 136	104 586	108 552	12 060	6 370	30 495	8 029	4 346	500	0	320	1 059	720	1 487	1 932	2 351
Other Current Liabilities	6 171	8 811	7 993	11 552	10 157	11 872	11 683	18 787	16 446	16 256	9 072	8 823	13 146	10 530	11 571	15 384	6 202	15 312	11 982	68 386	8 465	6 952	7 655	7 169
Total Current Liabilities	43 120	44 955	59 337	62 837	68 719	73 371	74 586	88 939	106 246	166 987	154 508	156 659	152 632	180 509	184 245	167 018	139 076	146 171	133 953	83 337	28 550	27 167	76 385	75 844
Long-Term Debt	12 414	9 396	9 011	11 015	8 002	2 461	13 708	36 764	39 695	20 300	19 849	11 606	30 114	9 834	4 473	8 050	9 550	2 000	7 664	576	213	1 008	219	4 941
Deferred Income Tax	0	0	0	455	1 316	2 612	869	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	788	259	219	245	190	365	343	299	301	248	288	302	305	303	300	1 013	945	959	1 067	1 151	1 196	1 269
Other Liabilities	5 507	7 006	9 253	13 108	14 385	16 348	14 192	14 971	18 899	25 220	24 283	22 689	24 824	27 438	27 151	24 572	26 875	25 300	29 368	28 907	9 263	2 603	2 698	3 218
Total Liabilities	61 041 N/A	61 356 +1%	78 388 +28%	87 674 +12%	92 640 +6%	95 037 +3%	103 545 +9%	141 039 +36%	165 183 +17%	212 806 +29%	198 941 -7%	191 202 -4%	207 857 +9%	218 083 +5%	216 174 -1%	199 943 -8%	175 800 -12%	174 484 -1%	171 930 -1%	113 778 -34%	39 093 -66%	31 929 -18%	80 498 +152%	85 272 +6%
Equity
Common Stock	19 893	20 055	20 118	20 118	20 118	20 118	20 118	20 118	20 118	20 118	20 644	21 366	22 117	22 897	23 709	27 592	27 592	27 592	27 592	27 592	27 592	27 592	27 592	27 592
Retained Earnings	11 777	31 340	43 935	44 906	55 682	76 265	83 479	93 750	99 050	128 137	149 798	161 042	163 498	162 882	162 243	146 604	148 218	147 841	146 463	156 595	144 925	115 830	55 331	38 943
Additional Paid In Capital	21 393	21 716	21 845	21 515	21 505	21 505	21 548	21 544	21 544	21 544	21 527	21 524	21 522	21 521	21 519	57 635	57 635	57 635	0	57 775	57 775	57 775	57 775	57 775
Unrealized Security Profit/Loss	1 917	1 942	2 200	1 342	1 045	998	1 288	3 657	2 756	374	20	2 590	3 531	0	121	2 637	5 423	10 119	11 738	14 527	18 705	19 824	19 166	17 039
Treasury Stock	0	0	0	0	0	11 626	11 626	11 626	11 626	11 626	11 653	11 659	11 668	11 677	11 688	11 688	11 688	11 688	0	8 734	8 734	8 734	8 734	8 734
Other Equity	0	0	294	781	916	1 230	1 192	97	878	544	738	1 205	1 441	4 410	1 105	961	1 506	617	45 867	154 670	156 404	156 968	156 787	158 283
Total Equity	54 981 N/A	75 053 +37%	87 804 +17%	87 101 -1%	97 435 +12%	106 031 +9%	113 616 +7%	127 541 +12%	130 964 +3%	157 256 +20%	179 559 +14%	188 477 +5%	190 497 +1%	191 213 +0%	194 556 +2%	216 545 +11%	214 830 -1%	210 646 -2%	208 184 -1%	373 371 +79%	359 257 -4%	329 607 -8%	269 586 -18%	256 821 -5%
Total Liabilities & Equity	116 022 N/A	136 409 +18%	166 193 +22%	174 775 +5%	190 075 +9%	201 068 +6%	217 161 +8%	268 580 +24%	296 147 +10%	370 062 +25%	378 500 +2%	379 680 +0%	398 355 +5%	409 295 +3%	410 730 +0%	416 488 +1%	390 630 -6%	385 129 -1%	380 114 -1%	487 150 +28%	398 350 -18%	361 536 -9%	350 084 -3%	342 093 -2%
Shares Outstanding
Common Shares Outstanding	45	46	46	46	46	40	40	40	40	40	38	38	40	39	40	48	48	48	48	49	49	49	49	49
Preferred Shares Outstanding	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2

Income Statement Balance Sheet Cash Flow Statement

Shinpoong Pharmaceutical Co Ltd
KRX:019170

Balance Sheet

Balance Sheet Decomposition
Shinpoong Pharmaceutical Co Ltd

Balance Sheet
Shinpoong Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Shinpoong Pharmaceutical Co Ltd KRX:019170

Balance Sheet

Balance Sheet Decomposition Shinpoong Pharmaceutical Co Ltd

Balance Sheet Shinpoong Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Shinpoong Pharmaceutical Co Ltd
KRX:019170

Balance Sheet Decomposition
Shinpoong Pharmaceutical Co Ltd

Balance Sheet
Shinpoong Pharmaceutical Co Ltd